Unleashing the future of vaccines: MVADS 2023
Croda is proud to be a sponsor for Modern Vaccines Adjuvants and Delivery Systems (MVADS 2023).
Taking place in Copenhagen from May 31st to June 2nd, this global conference will focus on sharing the latest developments on the new adjuvants, delivery systems, and technologies that are helping foster modern vaccine strategies and research.
Our very own Global Head of R&D, Dennis Christensen, will act as conference chairman and speak on how to secure the supply chain for vaccine adjuvants in the future.
MVADS will feature a stellar line-up of keynote speakers and leading scientists who will share their invaluable insights and research findings. Expect comprehensive talks on:
- Mechanistic interpretations
- Formulation and design
- Modern vaccines and adjuvants
- Future developments.
The conference will close with a panel discussion, featuring moderators from notable global organisations and universities. You can find the full programme here.
Who’s it for?
This conference will be of particular interest to researchers and contributors from academic programs, as well as industrial, governmental, and regulatory groups.
When is it?
31 May – 2nd June 2023 in Copenhagen, Denmark
Connect with us!
This is a fantastic opportunity to gain access to the latest advancements in vaccine development and emerging trends. Our team will be available throughout the conference to answer all your questions on modern vaccine development. Let’s start the discussion and build the vaccines of the future together.
Contact us below and book your meeting today!
Event type: Exhibition
Modern Vaccines Adjuvants & Delivery Systems
The drive for the new generation of vaccine therapies has precipitated a concurrent need for new and improved adjuvantation/delivery systems for these new vaccines. This new international conference will focus on updating the community on new adjuvant/delivery systems/technologies associated with developing modern vaccines strategies and vaccine research. There is now an urgent need for the development of these potent and safe adjuvants and delivery systems and MVADS 2023 will offer researchers a fresh forum to discuss this important topic in detail. MVADS 2023 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.